TRPM2 and breast carcinoma: The discovery of a unique role for TRPM2 in breast cancer cells, along with the ability of TRPM2 inhibition or RNAi silencing to increase DNA damage and decrease cell proliferation specifically in breast cancer cells, suggests that the pharmacologic inhibition of TRPM2 may specifically target breast tumors.